Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: Cheplapharm E300m 7.50% sr sec 05/15/30 add-on at 100.50

HYC European Market: Deal Flow - General

Cheplapharm Arzneimittal GmbH (CHEPDE) EUR300m 144A/Reg S add-on to its 7.50% sr sec fixed rate notes due 05/15/30 (6.5y). NC2.5 (05/15/26) (MWC B+50bp), then at 103.75, 101.875, 100. Equity claw: 2.5y 40% at 107.50. Special call: 10% per year the first 2.5 years at 103.. B2/B+/BB- (stable/stable/stable). Via DB/JPM (B&D) jt glocos and books. No reg rights. List ISE. NY law. Semi pay starting 11/15/23. Settles 09/29 (T+8). Reg S ISIN: existing XS2618867159; temporary XS2695600960. Immediately 144A fungible (Reg S after 40 days) with the EUR425m issue priced 04/26/23. IPT: 100 area (+/-0.25%). Px talk: 100.50 area (+/- 0.25 point). Launched: EUR300m at 100.50.

Priced: 7.50% add-on at 100.50, yield 7.401%. +473bp vs DBR 0% 08/15/30.

Originally 2-part deal with an FRN tranche, which was dropped: EUR add-on to its sr sec FRN due 05/15/30 (6.5y). NC0.5 (05/15/24) (MWC B+50bp), then at 101, 100. Floats/pays quarterly starting 11/15/23. 3mE+475bp (0% floor). IPT: 100 area (+/-0.25%).  Px talk: 100.50 area (+/- 0.25 point). Did investor call at 11am UKT yesterday. Books closed at 1:30pm UKT today. Reconfirms were due by 2:45pm UKT today. UOP: GCP. Biz: specialty pharmaceuticals. HQ: Greifswald, Germany.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.